International Agency for Research on Cancer (IARC) - Summaries & Evaluations
17a-HYDROXYPROGESTERONE CAPROATE
VOL.: 21 (1979) (p. 399)
5. Summary of Data Reported and Evaluation
5.1 Experimental data
17a-Hydroxyprogesterone caproate was tested in rabbits by
repeated intramuscular injection. The data were insufficient to
evaluate the carcinogenicity of this compound.
5.2 Human data
No case reports or epidemiological studies on 17a-hydroxyprogesterone caproate were available to the Working Group.
5.3 Evaluation
The available experimental and human data are inadequate to evaluate
the carcinogenicity of 17a-hydroxyprogesterone caproate.
For definition of the italicized terms, see Preamble Evaluation.
Subsequent evaluation: Suppl. 7 (1987) (Progestins)
Last updated: 6 April 1998